نتایج جستجو برای: edss

تعداد نتایج: 1456  

Journal: :AJNR. American journal of neuroradiology 2002
Fabrice Bonneville David M Moriarty Belinda S Y Li James S Babb Robert I Grossman Oded Gonen

BACKGROUND AND PURPOSE The T2-weighted MR imaging total lesion volume and Expanded Disability Status Scale (EDSS) score are two common measures of relapsing-remitting multiple sclerosis disability and pathologic abnormality. Because the whole-brain N-acetylaspartate concentration is considered to be a new marker of the disease burden, the purpose of this study was to evaluate the relationship a...

Journal: :Arquivos de neuro-psiquiatria 2017
Claudia Beatriz de Campos Lotti Acary Souza Bulle Oliveira Denis Bernardi Bichuetti Isac de Castro Enedina Maria Lobato Oliveira

Late onset multiple sclerosis (LOMS) is when the first symptom starts after 50 years of age, representing 4.5% of multiple sclerosis (MS) patients. This study describes the clinical characteristics of patients with LOMS followed at a specialized MS center in São Paulo. Data was obtained from medical records of 742 patients with MS. The LOMS frequency was 4.18%, median age at onset was 54 years ...

2010
David A. Swayne Wanhong Yang A. A. Voinov

The mantra that successful Environmental Decision Support Systems (EDSS’s) are those that benefit from a high level of end-user involvement during the design phase and subsequent implementation is well founded. However the practical matter of eliciting the relevant information from stakeholders to develop a useful and robust EDSS is rarely adequate and this weakness contributes to the high rate...

Journal: :Multiple sclerosis 2016
J Kuhle M Hardmeier G Disanto K Gugleta M Ecsedi C Lienert M P Amato K Baum M Buttmann A Bayas D Brassat B Brochet C Confavreux G Edan M Färkkilä S Fredrikson M Frontoni M D'Hooghe M Hutchinson J De Keyser B C Kieseier T Kümpfel J Rio C Polman E Roullet C Stolz K Vass K P Wandinger L Kappos

OBJECTIVES To explore long-term effects of treatment and prognostic relevance of variables assessed at baseline and during the European secondary progressive multiple sclerosis (SPMS) trial of interferon beta 1b (IFNB-1b). METHODS We assessed 362 patients (60% female; median age 41 years; Expanded Disability Status Scale (EDSS): 5.5; 51% randomized to IFNB-1b) for their EDSS and treatment his...

Journal: :Environmental Modelling and Software 2011
Brian S. McIntosh James C. Ascough Mark J. Twery Jimmie Chew Amgad Elmahdi Dagmar Haase Julien J. Harou Daryl H. Hepting Susan M. Cuddy Anthony J. Jakeman Serena H. Chen Ayalew Kassahun Sven Lautenbach Keith Matthews Wendy S. Merritt Nigel W. T. Quinn Ignasi Rodríguez-Roda Stefan Sieber Marten Stavenga Andrea Sulis Jenifer L. Ticehurst Martin Volk Markus Wrobel Hedwig van Delden Sondoss El Sawah Andrea Emilio Rizzoli Alexey A. Voinov

Despite the perceived value of DSS in informing environmental and natural resource management, DSS tools often fail to be adopted by intended end users. By drawing together the experience of a global group of EDSS developers, we have identified and assessed key challenges in EDSS development and offer recommendations to resolve them. Challenges related to engaging end users in EDSS development ...

Journal: :Brain : a journal of neurology 2000
J Hobart J Freeman A Thompson

When developing his disability scales for multiple sclerosis, Kurtzke demonstrated perception and insight. However, 45 years later, the evaluation of his clinically derived scales remains limited, particularly for more disabled patients. Indeed, many of Kurtzke's assumptions underpinning the development of the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) are untested. Thi...

2016
Christian DE Collins Ben Ivry James D Bowen Eric M Cheng Ruth Dobson Douglas S Goodin Jeannette Lechner-Scott Ludwig Kappos Ian Galea

BACKGROUND Patient-Reported Expanded Disability Status Scale (PREDSS) tools are an attractive alternative to the Expanded Disability Status Scale (EDSS) during long term or geographically challenging studies, or in pressured clinical service environments. OBJECTIVES Because the studies reporting these tools have used different metrics to compare the PREDSS and EDSS, we undertook an individual...

2017
Marcus W. Koch Gary R. Cutter Gavin Giovannoni Bernard M.J. Uitdehaag Jerry S. Wolinsky Mat D. Davis Joshua R. Steinerman Volker Knappertz

OBJECTIVE To assess the comparative utility of disability progression measures in primary progressive MS (PPMS) using the PROMiSe trial data set. METHODS Data for patients randomized to placebo (n = 316) in the PROMiSe trial were included in this analysis. Disability was assessed using change in single (Expanded Disability Status Scale [EDSS], timed 25-foot walk [T25FW], and 9-hole peg test [...

2000
Clarence Liu Lance D Blumhardt

Objectives—Recent phase III clinical trials of immunomodulatory therapies in relapsing-remitting multiple sclerosis have shown significant benefits of active treatment on relapse related end points, but eVects on disability outcomes have been inconsistent. These apparent discrepancies could be due to diVerences in the clinical end points employed, the behaviour of placebo cohorts, or both. Meth...

2016
Xavier Giffroy Nathalie Maes Adelin Albert Pierre Maquet Jean-Michel Crielaard Dominique Dive

BACKGROUND Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease course and identify patients exposed to unfavourable evolution. METHODS One hundred ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید